Dr. Tatjana Kolevska, MD
Claim this profileKaiser Permanente-Vallejo
Studies Skin Cancer
Studies Cutaneous Melanoma
22 reported clinical trials
52 drugs studied
Area of expertise
1Skin Cancer
Stage IV
Stage III
BRAF positive
2Cutaneous Melanoma
Stage IV
Stage III
BRAF positive
Affiliated Hospitals
Clinical Trials Tatjana Kolevska, MD is currently running
Chemotherapy + Immunotherapy
for Esophageal and Gastric Cancer
This phase III trial compares the effect of modified fluorouracil, leucovorin calcium, oxaliplatin, and irinotecan (mFOLFIRINOX) to modified fluorouracil, leucovorin calcium, and oxaliplatin (mFOLFOX) for the treatment of advanced, unresectable, or metastatic HER2 negative esophageal, gastroesophageal junction, and gastric adenocarcinoma. The usual approach for patients is treatment with FOLFOX chemotherapy. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Fluorouracil stops cells from making DNA and it may kill tumor cells. Leucovorin is used with fluorouracil to enhance the effects of the drug. Oxaliplatin works by killing, stopping, or slowing the growth of tumor cells. Some patients also receive an immunotherapy drug, nivolumab, in addition to FOLFOX chemotherapy. Immunotherapy may induce changes in body's immune system and may interfere with the ability of tumor cells to grow and spread. Irinotecan blocks certain enzymes needed for cell division and DNA repair, and it may kill tumor cells. Adding irinotecan to the FOLFOX regimen could shrink the cancer and extend the life of patients with advanced gastroesophageal cancers.
Recruiting2 awards Phase 32 criteria
Multiple Targeted Therapies
for Meningioma
This trial studies four drugs to treat patients with worsening meningioma. These drugs work by blocking enzymes that the tumor cells need to grow. The trial focuses on patients whose tumors have specific genetic mutations.
Recruiting1 award Phase 210 criteria
More about Tatjana Kolevska, MD
Clinical Trial Related2 years of experience running clinical trials · Led 22 trials as a Principal Investigator · 10 Active Clinical TrialsTreatments Tatjana Kolevska, MD has experience with
- Nivolumab
- Ipilimumab
- Pembrolizumab
- Lenalidomide
- MFOLFIRINOX
- Carboplatin
Breakdown of trials Tatjana Kolevska, MD has run
Skin Cancer
Cutaneous Melanoma
Pancreatic Cancer
Thyroid Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Tatjana Kolevska, MD specialize in?
Tatjana Kolevska, MD focuses on Skin Cancer and Cutaneous Melanoma. In particular, much of their work with Skin Cancer has involved Stage IV patients, or patients who are Stage III.
Is Tatjana Kolevska, MD currently recruiting for clinical trials?
Yes, Tatjana Kolevska, MD is currently recruiting for 10 clinical trials in Vallejo California. If you're interested in participating, you should apply.
Are there any treatments that Tatjana Kolevska, MD has studied deeply?
Yes, Tatjana Kolevska, MD has studied treatments such as Nivolumab, Ipilimumab, Pembrolizumab.
What is the best way to schedule an appointment with Tatjana Kolevska, MD?
Apply for one of the trials that Tatjana Kolevska, MD is conducting.
What is the office address of Tatjana Kolevska, MD?
The office of Tatjana Kolevska, MD is located at: Kaiser Permanente-Vallejo, Vallejo, California 94589 United States. This is the address for their practice at the Kaiser Permanente-Vallejo.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.